ロード中...
Age Modifies the Response to Recombinant Human Thyrotropin
BACKGROUND: A standardized protocol is used to administer recombinant human thyrotropin (rhTSH) in preparation for diagnostic studies and treatment in patients with thyroid cancer. The expectation is that serum TSH concentrations will peak on the day after the second injection and will be sufficient...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2990279/ https://ncbi.nlm.nih.gov/pubmed/20954824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2010.0177 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|